GlassScriptPhysician profile
Steven D Bischof
NPI 1528088648
$946.24
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $846 · 2020: $100.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $226.22 | 2019 | |
| Novo Nordisk INC | $146.12 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $128.34 | 2019-2020 | |
| Lilly USA, LLC | $88.95 | 2019-2020 | |
| Amgen INC. | $66.48 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.42 | 2019-2020 | |
| Amarin Pharma, INC. | $49.87 | 2019-2020 | |
| Astellas Pharma US INC | $36.50 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $30.86 | 2019 | |
| Allergan, INC. | $26.10 | 2019 | |
| Novartis Pharmaceuticals Corporation | $19.21 | 2019 | |
| Sanofi-Aventis U.S. LLC | $17.93 | 2019 | |
| Hikma Pharmaceuticals USA | $14.57 | 2020 | |
| Sanofi Pasteur INC. | $13.62 | 2019 | |
| Daiichi Sankyo INC. | $12.11 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $10.94 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Bischof listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.